EMA Authorised: Zokinvy (Lonafarnib) — TMC Pharma (EU) Limited

View source ↗

Summary

The European Medicines Agency authorised Zokinvy (lonafarnib) for Hutchinson-Gilford progeria syndrome and laminopathies in the European Union. The marketing au…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hutchinson-gilford Progeria Syndrome
• Laminopathies

Drugs mentioned

• Zokinvy (Lonafarnib)

Snippet

Status: Authorised. Therapeutic area: Progeria;Laminopathies. MAH: TMC Pharma (EU) Limited. Decision date: 20/11/2025. Orphan medicine